771 related articles for article (PubMed ID: 25646195)
21. Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics.
Bertrand KA; Scott CG; Tamimi RM; Jensen MR; Pankratz VS; Norman AD; Visscher DW; Couch FJ; Shepherd J; Chen YY; Fan B; Wu FF; Ma L; Beck AH; Cummings SR; Kerlikowske K; Vachon CM
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):798-809. PubMed ID: 25716949
[TBL] [Abstract][Full Text] [Related]
22. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
[TBL] [Abstract][Full Text] [Related]
23. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.
Malkov S; Shepherd JA; Scott CG; Tamimi RM; Ma L; Bertrand KA; Couch F; Jensen MR; Mahmoudzadeh AP; Fan B; Norman A; Brandt KR; Pankratz VS; Vachon CM; Kerlikowske K
Breast Cancer Res; 2016 Dec; 18(1):122. PubMed ID: 27923387
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer.
Strand F; Humphreys K; Eriksson M; Li J; Andersson TM; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Int J Cancer; 2017 Jan; 140(1):34-40. PubMed ID: 27615710
[TBL] [Abstract][Full Text] [Related]
25. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
Brand JS; Czene K; Shepherd JA; Leifland K; Heddson B; Sundbom A; Eriksson M; Li J; Humphreys K; Hall P
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1764-72. PubMed ID: 25012995
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study.
Azam S; Lange T; Huynh S; Aro AR; von Euler-Chelpin M; Vejborg I; Tjønneland A; Lynge E; Andersen ZJ
Cancer Causes Control; 2018 Jun; 29(6):495-505. PubMed ID: 29671181
[TBL] [Abstract][Full Text] [Related]
27. AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes.
Nickson C; Arzhaeva Y; Aitken Z; Elgindy T; Buckley M; Li M; English DR; Kavanagh AM
Breast Cancer Res; 2013; 15(5):R80. PubMed ID: 24020331
[TBL] [Abstract][Full Text] [Related]
28. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
[TBL] [Abstract][Full Text] [Related]
29. Mammographic density and estrogen receptor status of breast cancer.
Ziv E; Tice J; Smith-Bindman R; Shepherd J; Cummings S; Kerlikowske K
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2090-5. PubMed ID: 15598766
[TBL] [Abstract][Full Text] [Related]
30. Using mammographic density to improve breast cancer screening outcomes.
Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
[TBL] [Abstract][Full Text] [Related]
31. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
[TBL] [Abstract][Full Text] [Related]
32. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
[TBL] [Abstract][Full Text] [Related]
33. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
[TBL] [Abstract][Full Text] [Related]
34. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
[TBL] [Abstract][Full Text] [Related]
35. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
[TBL] [Abstract][Full Text] [Related]
36. Positive predictive values by mammographic density and screening mode in the Norwegian Breast Cancer Screening Program.
Moshina N; Ursin G; Roman M; Sebuødegård S; Hofvind S
Eur J Radiol; 2016 Jan; 85(1):248-254. PubMed ID: 26724673
[TBL] [Abstract][Full Text] [Related]
37. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
38. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.
Henderson LM; Miglioretti DL; Kerlikowske K; Wernli KJ; Sprague BL; Lehman CD
AJR Am J Roentgenol; 2015 Sep; 205(3):676-84. PubMed ID: 26295657
[TBL] [Abstract][Full Text] [Related]
39. Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
Kerlikowske K; Zhu W; Su YR; Sprague BL; Stout NK; Onega T; O'Meara ES; Henderson LM; Tosteson ANA; Wernli K; Miglioretti DL
J Natl Cancer Inst; 2024 Feb; 116(2):249-257. PubMed ID: 37897090
[TBL] [Abstract][Full Text] [Related]
40. PAM50 and Risk of Recurrence Scores for Interval Breast Cancers.
Puvanesarajah S; Nyante SJ; Kuzmiak CM; Chen M; Tse CK; Sun X; Allott EH; Kirk EL; Carey LA; Perou CM; Olshan AF; Henderson LM; Troester MA
Cancer Prev Res (Phila); 2018 Jun; 11(6):327-336. PubMed ID: 29622545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
